Novartis fights patent rejection in Indian court

NEW DELHI (AP) -- In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec....

Read the whole article on AP Health

More from AP Health